Delivery Order SPE2DB20D1100-SPE2DB24FB3F9

Award Date 4/17/24
Potential Completion Date 4/18/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, which has a total potential value of $4,847.35, is a Delivery Order awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This single-award IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary...
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,372.95 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,564,590,859 units of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order with a ceiling value of $14,029.50. The contract is for the supply of a specific pharmaceutical product, Fluticasone-Salmeterol 230-21 12GM, to the Defense Logistics Agency (DLA). The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products, specifically Fluticasone-Salmeterol 115-21 12GM, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,298.98 and is a firm fixed-price delivery order that runs through June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $8,396.59 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM pharmaceutical products and has a completion date of May 1, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,878.27 and is a Firm Fixed Price Delivery Order with a completion date of May 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical products. The $2,619.09 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,780.25 and a completion date of June 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division for the supply of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. The award has a ceiling value of $2,262.75 and an ultimate completion date of August 20, 2024. The contract is a Firm Fixed Price instrument. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to...
This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Fluticasone-Salmeterol 115-21 12GM medication. The contract has a ceiling value of $9,996.53 and a completion date of June 27, 2024. This award is made under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB3F9
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,455.36 and an ultimate completion date of April 18, 2024. It is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 7/17/24, 9:27 AM